Lei Chen

Lei Chen is an accomplished professional in health economics and outcomes research (HEOR) with extensive experience across multiple leading pharmaceutical companies. Currently serving as the Executive Director of HEOR at Mural Oncology, Lei has previously held key roles including Head of HEOR at ADC Therapeutics and Global HEOR Lead for an early heart failure asset at Bristol-Myers Squibb. At Novartis, Lei occupied several positions, notably as Director of Global Market Access for Melanoma and as Director of US Oncology HEOR. Early career experience includes serving as Senior Manager of US Evidence-Based Medicine at sanofi-aventis. Lei Chen holds a PhD in Pharmaceutical Economics & Policy from the University of Southern California and an MD from Beijing Medical University.